Genus plc
British biotechnology company
London SE
ISIN GB0002074580 LEI 54930022EOITNKSIGH56
Follow Genus
Weekly email: filings, results
Revenue, last year
£658.1M
−2.2% vs prior year
Net income
£285.3M
+1378.2% vs prior year
EPS, diluted
£4.25
+1370.9% vs prior year
Operating cash flow
£74.4M
+10.7% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | £658.1M | £285.3M |
| FY25 | £672.8M | £19.3M |
| FY24 | £668.8M | £7.9M |
| FY23 | £689.7M | £33.3M |
| FY22 | £593.4M | £40.9M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY26 | 13.3% | 43.4% |
| FY25 | 6.3% | 2.9% |
| FY24 | 1% | 1.2% |
| FY23 | 5.9% | 4.8% |
| FY22 | 8.3% | 6.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | £61.9M |
| FY25 | £53.8M |
| FY24 | £15M |
| FY23 | −£56.8M |
| FY22 | −£109.3M |
Show the numbers
| Year | Dividends |
|---|---|
| FY26 | £21.7M |
| FY25 | £21.1M |
| FY24 | £21M |
| FY23 | £21M |
| FY22 | £20.9M |
- Genus
- Healthcare median
Show the numbers
| Year | Genus | Healthcare median |
|---|---|---|
| FY26 | 43.4% | −11.1% |
| FY25 | 2.9% | −30.6% |
| FY24 | 1.2% | −47% |
| FY23 | 4.8% | −58% |
| FY22 | 6.9% | −80.4% |